Cargando…
OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Neuro-Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645107/ https://www.ncbi.nlm.nih.gov/pubmed/37974363 http://dx.doi.org/10.1097/WNO.0000000000001830 |
_version_ | 1785147321773719552 |
---|---|
author | Wong, David C. S. Harvey, Joshua P. Jurkute, Neringa Thomasy, Sara M. Moosajee, Mariya Yu-Wai-Man, Patrick Gilhooley, Michael J. |
author_facet | Wong, David C. S. Harvey, Joshua P. Jurkute, Neringa Thomasy, Sara M. Moosajee, Mariya Yu-Wai-Man, Patrick Gilhooley, Michael J. |
author_sort | Wong, David C. S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10645107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Journal of Neuro-Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-106451072023-11-15 OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets Wong, David C. S. Harvey, Joshua P. Jurkute, Neringa Thomasy, Sara M. Moosajee, Mariya Yu-Wai-Man, Patrick Gilhooley, Michael J. J Neuroophthalmol Perspective Journal of Neuro-Ophthalmology 2023-12 2023-04-19 /pmc/articles/PMC10645107/ /pubmed/37974363 http://dx.doi.org/10.1097/WNO.0000000000001830 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the North American Neuro-Opthalmology Society. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspective Wong, David C. S. Harvey, Joshua P. Jurkute, Neringa Thomasy, Sara M. Moosajee, Mariya Yu-Wai-Man, Patrick Gilhooley, Michael J. OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets |
title | OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets |
title_full | OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets |
title_fullStr | OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets |
title_full_unstemmed | OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets |
title_short | OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets |
title_sort | opa1 dominant optic atrophy: pathogenesis and therapeutic targets |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645107/ https://www.ncbi.nlm.nih.gov/pubmed/37974363 http://dx.doi.org/10.1097/WNO.0000000000001830 |
work_keys_str_mv | AT wongdavidcs opa1dominantopticatrophypathogenesisandtherapeutictargets AT harveyjoshuap opa1dominantopticatrophypathogenesisandtherapeutictargets AT jurkuteneringa opa1dominantopticatrophypathogenesisandtherapeutictargets AT thomasysaram opa1dominantopticatrophypathogenesisandtherapeutictargets AT moosajeemariya opa1dominantopticatrophypathogenesisandtherapeutictargets AT yuwaimanpatrick opa1dominantopticatrophypathogenesisandtherapeutictargets AT gilhooleymichaelj opa1dominantopticatrophypathogenesisandtherapeutictargets |